Detection of circulating tumor cells: Clinical relevance of a novel metastatic tumor marker
نویسندگان
چکیده
منابع مشابه
Detection of Circulating Tumor Cells
The increasing number of treatment options for patients with metastatic carcinomas has created an accompanying need for methods to determine if the tumor will be responsive to the intended therapy and to monitor its effectiveness. Ideally, these methods would be noninvasive and provide quantitative real-time analysis of tumor activity in a variety of carcinomas. Assessment of circulating tumor ...
متن کاملBiology, detection, and clinical implications of circulating tumor cells
Cancer metastasis is the main cause of cancer-related death, and dissemination of tumor cells through the blood circulation is an important intermediate step that also exemplifies the switch from localized to systemic disease. Early detection and characterization of circulating tumor cells (CTCs) is therefore important as a general strategy to monitor and prevent the development of overt metast...
متن کاملCirculating tumor cells (CTC) detection: clinical impact and future directions.
Recent molecular and clinical studies have shown that invasion may occur very early in tumor development, thus emphasizing the potential importance of specific and sensitive detection of circulating tumor cells (CTC) and circulating tumor microemboli (CTM). The technical challenge in this field consists of finding "rare" tumor cells (just a few CTCs mixed with the approximately 10 million leuko...
متن کاملCirculating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.
The role of circulating tumor cells (CTCs) as a marker for disease progression in metastatic cancer is controversial. The current review will serve to summarize the evidence on CTCs as a marker of disease progression in patients with metastatic breast cancer. The immunohistochemistry(IHC)-based CellSearch® is the only FDA-approved isolation technique for quantifying CTCs in patients with metast...
متن کاملCirculating Tumor Cells as a Prognostic Marker in Pancreatic Cancer
Pancreatic cancer, with a patient survival rate among the worst of any solid cancer, is the fourth leading cause of cancer-related morbidity and mortality in Western countries (Tjensvoll et al., 2013). It leads to an estimated 227, 000 deaths per year worldwide and the 5 year survival rate is only 4.6% due to its early metastasis (Zhou et al., 2011). Most of the pancreatic cancer patients are a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Experimental and Therapeutic Medicine
سال: 2011
ISSN: 1792-0981,1792-1015
DOI: 10.3892/etm.2011.234